Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com
Research analysts at StockNews.com started coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a report released on Wednesday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Up 5.8 % EVOK stock opened at $5.08 on Wednesday. The firm has a 50 day moving average […]
27 Sep 06:46 · The Markets Daily